ArticleClinical cancer research : an official journal of the American Association for Cancer Research2025

Phase I Clinical Trial of the Bifunctional EGFR/TGF-β Fusion Protein Ficerafusp Alfa (BCA101) Alone and in Combination with Pembrolizumab for Advanced Solid Tumors.

Alberto Hernando-Calvo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.